These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

224 related items for PubMed ID: 3549212

  • 1. Factors influencing the clinical efficacy of activated charcoal.
    Watson WA.
    Drug Intell Clin Pharm; 1987 Feb; 21(2):160-6. PubMed ID: 3549212
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Measures to reduce absorption in the treatment of intoxications].
    de Vries I, van Zoelen GA, van Riel AJ, Meulenbelt J.
    Ned Tijdschr Geneeskd; 2005 Dec 31; 149(53):2964-8. PubMed ID: 16425848
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Tricyclic antidepressant poisoning: an evidence-based consensus guideline for out-of-hospital management.
    Woolf AD, Erdman AR, Nelson LS, Caravati EM, Cobaugh DJ, Booze LL, Wax PM, Manoguerra AS, Scharman EJ, Olson KR, Chyka PA, Christianson G, Troutman WG.
    Clin Toxicol (Phila); 2007 Dec 31; 45(3):203-33. PubMed ID: 17453872
    [Abstract] [Full Text] [Related]

  • 6. Indications for single-dose activated charcoal administration in acute overdose.
    Isbister GK, Kumar VV.
    Curr Opin Crit Care; 2011 Aug 31; 17(4):351-7. PubMed ID: 21716104
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Out-of-hospital administration of activated charcoal by emergency medical services.
    Alaspää AO, Kuisma MJ, Hoppu K, Neuvonen PJ.
    Ann Emerg Med; 2005 Feb 31; 45(2):207-12. PubMed ID: 15671978
    [Abstract] [Full Text] [Related]

  • 9. Constraints on the enhancement of elimination of drugs with activated charcoal.
    Turk J, Aks SE, Hryhorczuk DO.
    Vet Hum Toxicol; 1993 Dec 31; 35(6):489-95. PubMed ID: 8303814
    [Abstract] [Full Text] [Related]

  • 10. Physicochemical characteristics of drugs and response to repeat-dose activated charcoal.
    Campbell JW, Chyka PA.
    Am J Emerg Med; 1992 May 31; 10(3):208-10. PubMed ID: 1586429
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Activated charcoal as first-choice therapy in poisoning].
    Pronk MJ, Versteegh FG.
    Ned Tijdschr Geneeskd; 1997 Apr 05; 141(14):675-7. PubMed ID: 9198768
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Use of activated charcoal in acute poisonings: clinical safety and factors associated with adverse reactions in 575 cases].
    Amigó M, Nogué S, Miró O.
    Med Clin (Barc); 2010 Jul 17; 135(6):243-9. PubMed ID: 20537361
    [Abstract] [Full Text] [Related]

  • 20. [Successful therapy of salicylate poisoning using glycine and activated charcoal].
    Mühlebach S, Steger P, Conen D, Wyss PA.
    Schweiz Med Wochenschr; 1996 Dec 07; 126(49):2127-9. PubMed ID: 8999500
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.